Suppr超能文献

包裹于脂质体中的诺考达唑:对人集落形成单位 - 细胞(CFU - C)的影响并不比游离诺考达唑更大。

Nocodazole entrapped into liposomes: no more effect on human CFU-C than free nocodazole.

作者信息

Loos M, Delforge A, Mattelaer M, Laduron C, Brassinne C, Hildebrand J, Stryckmans P

出版信息

Anticancer Res. 1981;1(6):393-6.

PMID:7344613
Abstract

Nocodazole, a water insoluble antimitotic drug active on L1210 leukemia was incorporated into liposomes, to investigate whether this procedure could increase cellular uptake. The effects of micronized nocodazole and liposome-entrapped nocodazole were compared on human marrow cells in vitro using a myeloid progenitor cell assay (CFU-C). The human CFU-C were sensitive to the micronized drug in a dose-related fashion. However, contrasting with a previous report on L 1210 leukemia, entrapping of nocodazole into liposomes did not increase its activity of CFU-C of either normal or leukemic subjects.

摘要

诺考达唑是一种对L1210白血病有效的水不溶性抗有丝分裂药物,将其包封于脂质体中,以研究该方法是否能增加细胞摄取。使用髓系祖细胞测定法(CFU-C)在体外比较了微粉化诺考达唑和脂质体包裹的诺考达唑对人骨髓细胞的作用。人CFU-C对微粉化药物呈剂量相关的敏感性。然而,与之前关于L1210白血病的报道相反,将诺考达唑包封于脂质体中并未增加其对正常或白血病受试者CFU-C的活性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验